Trial Summary:

SWIFT is the CTC’s first cluster randomised registry-based controlled trial. SWIFT aims to determine the clinical effectiveness and cost-effectiveness of 3-monthly symptom monitoring using the Integrated Palliative Outcome Scale – Renal (IPOS-Renal) survey, with feedback to clinicians, compared with standard care (i.e. no routine symptom monitoring) in improving outcomes at 12 months for adults on haemodialysis.

Supported By:

NHMRC Project Grant

Eligibility:

Adults aged 18 years and older with kidney failure managed with chronic haemodialysis at an Australian or New Zealand haemodialysis facility registered in ANZDATA.

Registration ID:

ACTRN12620001061921

Participation:

Australia

Australian Lead Group:

Collaboration between NHMRC CTC and ANZDATA Registry

Status:

Recruiting

Activation Date:

15 March 2021

Chairs:

Professor Rachael Morton (Chief Investigator)

Professor Stephen McDonald (Clinical Lead)

Contact:

swift.study@sydney.edu.au